Advertisement
Canada markets open in 2 hours 24 minutes
  • S&P/TSX

    21,587.88
    -51.22 (-0.24%)
     
  • S&P 500

    5,473.23
    +41.63 (+0.77%)
     
  • DOW

    38,778.10
    +188.94 (+0.49%)
     
  • CAD/USD

    0.7273
    -0.0016 (-0.22%)
     
  • CRUDE OIL

    80.17
    -0.16 (-0.20%)
     
  • Bitcoin CAD

    89,966.34
    -696.84 (-0.77%)
     
  • CMC Crypto 200

    1,360.84
    -28.56 (-2.06%)
     
  • GOLD FUTURES

    2,323.50
    -5.50 (-0.24%)
     
  • RUSSELL 2000

    2,022.01
    +15.85 (+0.79%)
     
  • 10-Yr Bond

    4.2790
    +0.0660 (+1.57%)
     
  • NASDAQ futures

    19,953.00
    +31.75 (+0.16%)
     
  • VOLATILITY

    12.66
    -0.09 (-0.71%)
     
  • FTSE

    8,176.86
    +34.71 (+0.43%)
     
  • NIKKEI 225

    38,482.11
    +379.67 (+1.00%)
     
  • CAD/EUR

    0.6785
    -0.0002 (-0.03%)
     

Monthly information on share capital and company voting rights

Cellectis Inc.
Cellectis Inc.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, May 16, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date

Total number of shares
in the capital

Total number of voting rights

05/03/2024

99,955,535

87,891,239


For further information on Cellectis, please contact:

Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com

Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577

Attachment